India's Biocon Developing Its Own Version of Wegovy, Clinical Trial Likely Next Year

Yahoo FinanceApr 19 00:20

Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years

Eli Lilly and Co (NYSE:LLY) has outperformed the market over the past 15 years by 10.71% on an annualized basis producing an average annual return of 23.13%. Currently, Eli Lilly and Co has a market c

BenzingaApr 18 22:30

Cantor Fitzgerald Company: Reiterates the Eli Lilly and Co (LLY.US) rating and adjusted from an increase to an increase in holdings rating, with a target price of $815.00.

Cantor Fitzgerald Company: Reiterates the Eli Lilly and Co (LLY.US) rating and adjusted from an increase to an increase in holdings rating, with a target price of $815.00.

Zhitong FinanceApr 18 22:01

Eli Lilly and Co Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/18/2024 9.21% Cantor Fitzgerald → $815 Reiterates Overweight → Overweight 04/15/2024 9.21% Cantor Fitzg

BenzingaApr 18 21:53

Company News for Apr 18, 2024

Yahoo FinanceApr 18 20:53

Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies

Yahoo FinanceApr 18 20:51